By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a




Company News
Cellectis (ALCLS) Announces Presentations At Upcoming Conferences 4/10/2015 11:27:15 AM
Cellectis (ALCLS) Opens Up Shop and Brings Engineered CAR-T Therapy to the Big Apple 4/9/2015 5:22:09 AM
Cellectis (ALCLS) Prices Initial Public Offering Of American Depositary Shares 3/25/2015 1:00:38 PM
Nasdaq Welcomes Cellectis (ALCLS) The Nasdaq Stock Market 3/25/2015 9:39:08 AM
Cancer Biotech Cellectis (ALCLS) Sets Terms For $129 Million IPO 3/20/2015 6:36:40 AM
ModiQuest Research And Cellectis (ALCLS) To Collaborate On Antibody Generation For Potential CAR Development 3/6/2015 9:29:48 AM
Cellectis (ALCLS): 2014 Financial Results 3/5/2015 11:02:46 AM
Cellectis (ALCLS) And Ohio State University, Through The Ohio State Innovation Foundation, Enter Into Licensing Agreement For Chimeric Antigen Receptor Technology Targeting Multiple Myeloma 1/13/2015 11:38:46 AM
Cellectis (ALCLS) Plans To Conduct Registered Initial Public Offering In The U.S. 1/9/2015 10:40:16 AM
Cellectis (ALCLS) Announces The Issuance By The USPTO Of A Patent Covering A Seminal Nuclease-Based “Gene Editing” Method 1/6/2015 2:34:32 PM